Frontlight ResearchEarly access
Trial site
New England Cancer Specialists - Kennebunk
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Melanoma2 trials
- Ovarian cancer2 trials
- Triple-negative breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Multiple myeloma1 trial
- and 3 more
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting6 trials
- Recruiting2 trials
- Lead sponsor
- National Cancer Institute (NCI)6 trials
- NRG Oncology1 trial
- SWOG Cancer Research Network1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026